Changes in gene expression induced by histamine, fexofenadine and osthole: Expression of histamine H1 receptor, COX-2, NF-κB, CCR1, chemokine CCL5/RANTES and interleukin-1β in PBMC allergic and non-allergic patients
Autor: | Elżbieta Kostyra, Anna Cieślińska, Michał Matysiewicz, Edyta Sienkiewicz-Szłapka, Natalia Karolina Kordulewska, Ewa Fiedorowicz |
---|---|
Rok vydání: | 2017 |
Předmět: |
0301 basic medicine
CCR1 Chemokine Fexofenadine biology business.industry medicine.medical_treatment Immunology Hematology Histamine H1 receptor Pharmacology Peripheral blood mononuclear cell CCL5 03 medical and health sciences chemistry.chemical_compound 030104 developmental biology chemistry medicine biology.protein Immunology and Allergy Antihistamine business Histamine medicine.drug |
Zdroj: | Immunobiology. 222:571-581 |
ISSN: | 0171-2985 |
DOI: | 10.1016/j.imbio.2016.11.004 |
Popis: | Introduction Fexofenadine (FXF) is a third-generation antihistamine drug and osthole is assumed as a natural antihistamine alternative. This paper compares results of histamine, FXF and osthole impact on HRH-1, COX-2, NF-κB-p50, CCR1 mRNA expression. We also measured mRNA expression of IL-1β and CCL5/RANTES in incubated peripheral blood mononuclear cells (PBMC) to compared how histamine, FXF and osthole had influence on expression level and interacts on product secretion. Objective The purpose was to investigate expression pattern in asthma PBMC. Methods The cultures were treated 72 h with FXF and osthole. We measured mRNA expression of histamine HRH-1, COX-2, NF-κB-p50, CCR1, IL-1β and CCL5/RANTES with Real-Time PCR (RT-PCR). Results The present study suggest that osthole may be a potential inhibitor of histamine H 1 receptor activity. We also demonstrated that cells cultured with histamine increase COX-2 mRNA expression and osthole reduce it. Conclusion Allergy remains one of the most common chronic diseases in Europe and it is rapidly approaching epidemic proportions; with current predictions estimating that the number of allergy-afflicted will equal the healthy population by 2020. It is therefore paramount to find new pharmaceuticals which successfully combat allergic disease. |
Databáze: | OpenAIRE |
Externí odkaz: |